Your browser doesn't support javascript.
loading
Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders.
Brown, Lauren J; Weppler, Alison; Bhave, Prachi; Allayous, Clara; Patrinely, J Randall; Ott, Patrick; Sandhu, Shahneen; Haydon, Andrew; Lebbe, Celeste; Johnson, Douglas B; Long, Georgina V; Menzies, Alexander A; Carlino, Matteo S.
Afiliación
  • Brown LJ; Department of Medical Oncology, Westmead and Blacktown Hospital, New South Wales, New South Wales, Australia.
  • Weppler A; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Bhave P; Department of Medical Oncology, Alfred Hospital, Melbourne, Victoria, Australia.
  • Allayous C; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, Île-de-France, France.
  • Patrinely JR; School of Medicine, Vanderbilt University, Nashville, Tennessee, Australia.
  • Ott P; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
  • Sandhu S; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Haydon A; Department of Medical Oncology, Alfred Hospital, Melbourne, Victoria, Australia.
  • Lebbe C; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, Île-de-France, France.
  • Johnson DB; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Menzies AA; Department of Medical Oncology, Mater and Royal North Shore Hospitals, Sydney, New South Wales, Australia.
  • Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
J Immunother Cancer ; 9(5)2021 05.
Article en En | MEDLINE | ID: mdl-33963010
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Enfermedades Autoinmunes / Protocolos de Quimioterapia Combinada Antineoplásica / Autoinmunidad / Anticuerpos Monoclonales Humanizados / Ipilimumab / Nivolumab / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Enfermedades Autoinmunes / Protocolos de Quimioterapia Combinada Antineoplásica / Autoinmunidad / Anticuerpos Monoclonales Humanizados / Ipilimumab / Nivolumab / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Australia